title: Application of method suitability for drug permeability classification.
abstract: Experimental models of permeability in animals, excised tissues, cell monolayers, and artificial membranes are important during drug discovery and development as permeability is one of several factors affecting the intestinal absorption of oral drug products. The utility of these models is demonstrated by their ability to predict a drug's in vivo intestinal absorption. Within the various permeability models, there are differences in the performance of the assays, along with variability in animal species, tissue sources, and cell types, resulting in a variety of experimental permeability values for the same drug among laboratories. This has led to a need for assay standardization within laboratories to ensure applicability in the drug development process. Method suitability provides a generalized approach to standardize and validate a permeability model within a laboratory. First, assay methodology is optimized and validated for its various experimental parameters along with acceptance criteria for the assay. Second, the suitability of the model is demonstrated by a rank order relationship between experimental permeability values and human extent of absorption of known model compounds. Lastly, standard compounds are employed to classify a test drug's intestinal permeability and ensure assay reproducibility and quality. This review will provide examples of the different aspects method suitability for in situ (intestinal perfusions), ex vivo (everted intestinal sacs, diffusion chambers), and in vitro (cell monolayers, artificial membranes) experimental permeability models. Through assay standardization, reference standards, and acceptance criteria, method suitability assures the dependability of experimental data to predict a drug's intestinal permeability during discovery, development, and regulatory application.
authors.affiliation: Center for Drug Evaluation and Research, Silver Spring, Maryland 20993-0002, USA. donna.volpe@fda.hhs.gov
authors.forename: Donna A
authors.initials: DA
authors.lastname: Volpe
mesh_terms: D000818:Animals; D006801:Humans; D008962:Models, Theoretical; D010539:Permeability; D010599:Pharmacokinetics
references.citation: Biochem Biophys Res Commun. 1991 Mar 29;175(3):880-5
references.pmid: 1673839
references.citation: Eur J Pharm Sci. 2005 Jun;25(2-3):193-200
references.pmid: 15911214
references.citation: Gastroenterology. 1989 Mar;96(3):736-49
references.pmid: 2914637
references.citation: Med Res Rev. 1995 Mar;15(2):83-109
references.pmid: 7537838
references.citation: Pharm Res. 2003 Dec;20(12):1961-9
references.pmid: 14725360
references.citation: J Pharm Belg. 2002 Nov-Dec;57(6):153-8
references.pmid: 12596572
references.citation: Mol Pharm. 2006 Nov-Dec;3(6):686-94
references.pmid: 17140256
references.citation: J Pharm Sci. 2004 Dec;93(12):2909-19
references.pmid: 15459890
references.citation: Mol Pharm. 2009 Jan-Feb;6(1):11-8
references.pmid: 19248229
references.citation: J Pharm Sci. 1998 Mar;87(3):360-6
references.pmid: 9523990
references.citation: Curr Top Med Chem. 2001 Nov;1(5):367-83
references.pmid: 11899103
references.citation: J Pharm Sci. 1969 Oct;58(10):1196-200
references.pmid: 5394662
references.citation: J Pharm Sci. 1999 Jan;88(1):28-33
references.pmid: 9874698
references.citation: J Med Chem. 2005 Jan 27;48(2):604-13
references.pmid: 15658873
references.citation: Eur J Med Chem. 2006 May;41(5):605-10
references.pmid: 16546303
references.citation: J Pharmacol Exp Ther. 1958 May;123(1):81-8
references.pmid: 13539795
references.citation: Eur J Pharm Sci. 2006 Mar;27(4):346-53
references.pmid: 16359848
references.citation: Eur J Pharm Sci. 2006 Mar;27(4):354-62
references.pmid: 16364612
references.citation: Eur J Pharm Sci. 2004 Mar;21(4):553-60
references.pmid: 14998587
references.citation: ALTEX. 2004;21 Suppl 3:57-64
references.pmid: 15057409
references.citation: Int J Clin Pharmacol Ther. 1998 Feb;36(2):86-9
references.pmid: 9520153
references.citation: J Pharm Sci. 2008 Feb;97(2):712-25
references.pmid: 17542022
references.citation: Eur J Pharm Sci. 2006 Apr;27(5):543-54
references.pmid: 16406207
references.citation: Pharm Res. 1998 Sep;15(9):1490-4
references.pmid: 9755906
references.citation: J Med Chem. 2001 Mar 15;44(6):923-30
references.pmid: 11300874
references.citation: Pharm Res. 1997 Dec;14(12):1792-7
references.pmid: 9453070
references.citation: Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):27-43
references.pmid: 11259831
references.citation: Drug Dev Ind Pharm. 2009 Dec;35(12):1496-502
references.pmid: 19929209
references.citation: Scand J Gastroenterol. 2000 May;35(5):501-7
references.pmid: 10868453
references.citation: J Pharmacol Exp Ther. 2002 Dec;303(3):889-95
references.pmid: 12438506
references.citation: Eur J Pharm Biopharm. 2006 Nov;64(3):369-78
references.pmid: 16905298
references.citation: J Pharm Pharmacol. 1997 Jul;49(7):627-38
references.pmid: 9255703
references.citation: Int J Pharm. 2000 Apr 25;200(1):41-51
references.pmid: 10845684
references.citation: Eur J Pharm Sci. 2006 Jan;27(1):80-90
references.pmid: 16246536
references.citation: Adv Drug Deliv Rev. 2002 Mar 31;54(3):273-89
references.pmid: 11922948
references.citation: Eur J Pharm Sci. 2000 Oct;11 Suppl 2:S51-60
references.pmid: 11033427
references.citation: Pharm Res. 1991 Aug;8(8):979-88
references.pmid: 1924168
references.citation: Pharm Res. 1997 Dec;14(12):1655-8
references.pmid: 9453050
references.citation: AAPS PharmSci. 2004 Apr 05;6(2):e13
references.pmid: 15760043
references.citation: J Med Chem. 1998 Mar 26;41(7):1007-10
references.pmid: 9544199
references.citation: J Pharm Pharmacol. 1997 Jul;49(7):687-90
references.pmid: 9255712
references.citation: Pharm Res. 1996 Sep;13(9):1336-42
references.pmid: 8893271
references.citation: Curr Top Med Chem. 2001 Nov;1(5):385-401
references.pmid: 11899104